Using high-specific activity Samarium-153 for the development of [153Sm] Sm DOTA-TATE for targeted radionuclide therapy of neuroendocrine tumors

被引：0
|
作者：
Vermeulen, Koen [1 ]
Van de Voorde, Michiel [1 ]
Daems, Noami [1 ]
Duchemin, Charlotte [2 ,3 ]
Rodriguez, Sunay [1 ]
Crabbe, Melissa [1 ]
Heinke, Reinhard [3 ]
Ponsard, Bernard [4 ]
Geenen, Lorain [1 ]
Nonnekens, Julie [5 ]
Lambert, Laura [6 ]
Bernerd, Cyril [3 ]
Burgoyne, Andrew [1 ]
Cocolios, Thomas [3 ]
Stora, Thierry [2 ]
Ooms, Maarten [1 ]
机构：
[1] Belgian Nucl Res Ctr, Mol, Belgium
[2] CERN, Meyrin, Switzerland
[3] Katholieke Univ Leuven, Leuven, Belgium
[4] SCK CEN, Mol, Belgium
[5] Erasmus MC, Rotterdam, Netherlands
[6] European Org Nucl Res CERN, Meyrin, Switzerland
来源：
NUCLEAR MEDICINE AND BIOLOGY | 2022年 / 108卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
O-27
引用
收藏
页码：S20 / S20
页数：1
相关论文
共 10 条
  • [1] Exploring the potential of high-specific activity Samarium-153 for targeted radionuclide therapy with [153Sm]Sm-DOTA-TATE
    Segers, C.
    Vermeulen, K.
    Van De Voorde, M.
    Daems, N.
    Duchemin, C.
    Rodriguez, S. Perez
    Crabbe, M.
    Heinke, R.
    Ponsard, B.
    Geenen, L.
    Nonnekens, J.
    Lambert, L.
    Bernerd, C.
    Burgoyne, A.
    Cocolios, T. E.
    Stora, T.
    Ooms, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S650 - S651
  • [2] Exploring the potential of high-specific activity samarium-153 for targeted radionuclide therapy with [153Sm]Sm-DOTA-TATE
    Vermeulen, Koen
    Van de Voorde, Michiel
    Daems, Noami
    Duchemin, Charlotte
    Rodriguez, Sunay
    Crabbe, Melissa
    Heinke, Reinhard
    Ponsard, Bernard
    Geenen, Lorain
    Nonnekens, Julie
    Lambert, Laura
    Segers, Charlotte
    Bernerd, Cyril
    Burgoyne, Andrew
    Cocolios, Thomas
    Stora, Thierry
    Ooms, Maarten
    NUCLEAR MEDICINE AND BIOLOGY, 2022, 114 : S57 - S57
  • [3] Exploring the Potential of High-Molar-Activity Samarium-153 for Targeted Radionuclide Therapy with [153Sm]Sm-DOTA-TATE
    Vermeulen, Koen
    Van de Voorde, Michiel
    Segers, Charlotte
    Coolkens, Amelie
    Perez, Sunay Rodriguez
    Daems, Noami
    Duchemin, Charlotte
    Crabbe, Melissa
    Opsomer, Tomas
    Vargas, Clarita Saldarriaga
    Heinke, Reinhard
    Lambert, Laura
    Bernerd, Cyril
    Burgoyne, Andrew R.
    Cocolios, Thomas Elias
    Stora, Thierry
    Ooms, Maarten
    PHARMACEUTICS, 2022, 14 (12)
  • [4] Production of Sm-153 with high specific activity for targeted radionuclide therapy
    Van de Voorde, M.
    Duchemin, C.
    Heinke, R.
    Lambert, L.
    Chevallay, E.
    Cocolios, T. E.
    Cardinaels, T.
    Ponsard, B.
    Ooms, M.
    Stora, T.
    Burgoyne, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S410 - S410
  • [5] Radionuclide therapy with samarium-oxabiphore, 153Sm for painful bone metastases
    Krylov, V. V.
    Tsyb, A. F.
    Drozdovsky, B. Y.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S335 - S335
  • [6] Production of Sm-153 With Very High Specific Activity for Targeted Radionuclide Therapy
    Van de Voorde, Michiel
    Duchemin, Charlotte
    Heinke, Reinhard
    Lambert, Laura
    Chevallay, Eric
    Schneider, Thomas
    Van Stenis, Miranda
    Cocolios, Thomas Elias
    Cardinaels, Thomas
    Ponsard, Bernard
    Ooms, Maarten
    Stora, Thierry
    Burgoyne, Andrew R.
    FRONTIERS IN MEDICINE, 2021, 8
  • [7] Comparison of Renal Elimination of [111In]-DOTA-Tate, [153Sm]-DOTA-Tate and DOTA-[125I]-Tyr3-Octreotate in Perfused Rat Kidney
    Trejtnar, F.
    Laznickova, A.
    Laznicek, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S278 - S278
  • [8] Residual whole body 153Samarium activity predicts for successful autologous peripheral blood progenitor cell (PBPC) engraftment following high dose 153Samarium ethylene diamine tetramethylene phosphonate (153Sm-EDTMP) targeted radiotherapy.
    Wiseman, GA
    Dispenzieri, A
    Anderson, PM
    Lacy, MQ
    Litzow, MR
    Gertz, MA
    BLOOD, 2000, 96 (11) : 421A - 421A
  • [9] Intravenous and intra-arterial peptide receptor radionuclide therapy (PRRT) using Y-90-DOTA-Tyr3-OCTREOTATE (Y-90 DOTA-TATE) in patients with metastatic neuroendocrine tumors
    Baum, RP
    Söldner, J
    Schmücking, M
    Niesen, A
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S238 - S238
  • [10] In Vitro and In Vivo Evaluation of Melanin-Binding Decapeptide 4B4 Radiolabeled with 177Lu, 166Ho, and 153Sm Radiolanthanides for the Purpose of Targeted Radionuclide Therapy of Melanoma
    Ballard, Beau
    Jiang, Zewei
    Soll, Clifford E.
    Revskaya, Ekaterina
    Cutler, Cathy S.
    Dadachova, Ekaterina
    Francesconi, Lynn C.
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2011, 26 (05) : 547 - 556
1